{"paper_id": "8f572d6d1c2593b07242b1df28dc4e394f7130bf", "metadata": {"title": "Comparison of Hospitalized Patients with pneumonia caused by COVID-19 and influenza A in children under 5 years", "authors": [{"first": "Ying", "middle": [], "last": "Li", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Haizhou", "middle": [], "last": "Wang", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Fan", "middle": [], "last": "Wang", "suffix": "", "affiliation": {"laboratory": "", "institution": "Wuhan Children' Hospital", "location": {"settlement": "Wuhan", "country": "China"}}, "email": ""}, {"first": "Hui", "middle": [], "last": "Du", "suffix": "", "affiliation": {"laboratory": "", "institution": "Wuhan Children' Hospital", "location": {"settlement": "Wuhan", "country": "China"}}, "email": ""}, {"first": "Xueru", "middle": [], "last": "Liu", "suffix": "", "affiliation": {"laboratory": "", "institution": "Wuhan Children' Hospital", "location": {"settlement": "Wuhan", "country": "China"}}, "email": ""}, {"first": "Peng", "middle": [], "last": "Chen", "suffix": "", "affiliation": {"laboratory": "", "institution": "Wuhan Children' Hospital", "location": {"settlement": "Wuhan", "country": "China"}}, "email": ""}, {"first": "Yanli", "middle": [], "last": "Wang", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Xiaoxia", "middle": [], "last": "Lu", "suffix": "", "affiliation": {"laboratory": "", "institution": "Wuhan Children' Hospital", "location": {"settlement": "Wuhan", "country": "China"}}, "email": ""}, {"first": "Y", "middle": [], "last": "Li", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Wang", "middle": ["H"], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Wang", "middle": ["F"], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Du", "middle": ["H"], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Liu", "middle": ["X"], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Chen", "middle": ["P"], "last": "Wang", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Y", "middle": [], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Lu", "middle": ["X"], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Xiaoxia", "middle": ["Lu"], "last": "Md", "suffix": "", "affiliation": {"laboratory": "", "institution": "Wuhan Children' Hospital", "location": {"settlement": "Wuhan", "country": "China"}}, "email": ""}]}, "abstract": [{"text": "Background: Since the outbreak of Coronavirus Disease 2019 in Wuhan, considerable attention has been paid on its epidemiology and clinical characteristics in children patients. However, it is also crucial for clinicians to differentiate COVID-19 from other respiratory infectious diseases, such as influenza viruses.", "cite_spans": [], "ref_spans": [], "section": "Abstract"}, {"text": "Methods: This was a retrospective study. Two group of COVID-19 patients (n=57) and influenza A patients (n=59) were enrolled. We analyzed and compared their clinical manifestations, imaging characteristics and treatments.", "cite_spans": [], "ref_spans": [], "section": "Abstract"}, {"text": "The proportions of cough (70.2%), fever (54.4%) and gastrointestinal symptoms (14.1%) in COVID-19 patients were lower than those of influenza A patients (98.3%, P < 0.001; 84.7%, P <0.001; and 35.6%, P = 0.007; respectively). In addition, COVID-19 patients showed significantly lower levels of leukocytes (7.87 vs. 9.89 \u00d710 9 /L, P = 0.027), neutrophils (2.43 vs. 5.16 \u00d710 9 /L, P < 0.001), C-reactive protein (CRP; 3.7 vs. 15.1 mg/L, P = 0.001) and procalcitonin (PCT; 0.09 vs. 0.68 mm/h, P < 0.001), while lymphocyte levels (4.58 vs. 3.56 \u00d7109/L; P = 0.006) were significantly higher compared with influenza A patients. In terms of CT imaging, ground-glass opacification in chest CT was more common in COVID-19 patients than in influenza A patients (42.1% vs. 15%, P = 0.032). In contrast, consolidation was more common in influenza A patients (25%) than that in COVID-19 patients (5.2%, P = 0.025).", "cite_spans": [], "ref_spans": [], "section": "Abstract"}, {"text": "The clinical manifestations and laboratory tests of COVID-19 children are milder than those of influenza A children under 5 years. Additionally, imaging results more commonly presented as ground-glass opacities in COVID-19 patients.", "cite_spans": [], "ref_spans": [], "section": "Abstract"}], "body_text": [{"text": "The clinical manifestations of COVID-19 children are milder than those of influenza A children under 5 years.", "cite_spans": [], "ref_spans": [], "section": ""}, {"text": "The laboratory tests of COVID-19 children are milder than those of influenza A children under 5 years.", "cite_spans": [], "ref_spans": [], "section": "2."}, {"text": "Imaging results more commonly presented as ground-glass opacities in COVID-19", "cite_spans": [], "ref_spans": [], "section": "3."}, {"text": "patients.", "cite_spans": [], "ref_spans": [], "section": "3."}, {"text": "Since December 2019, a novel coronavirus has broken out in Wuhan, and spread rapidly worldwide. On February 11, 2020, the World Health Organization (WHO) officially named this novel coronavirus pneumonia as Coronavirus Disease 2019 , whereas the International Committee on Taxonomy of Viruses has named it as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). On 11 March, WHO declared the COVID-19", "cite_spans": [], "ref_spans": [], "section": "INTRODUCTION"}, {"text": "should be characterized as a pandemic. As the highly contagious of SARS-CoV-2, the entire population were generally susceptible, including young children. Data from China showed young children were vulnerable to SARS-CoV-2 infection (Dong et al., 2020) . In addition, WHO estimated that more than more than 2 million children under 5 years of age die from pneumonia, accounting for almost one in five under-5 deaths worldwide in 2004 (Wardlaw et al., 2006) . Pneumonia was the leading infectious cause of death in children younger than 5 years (Wardlaw et al., 2006) . Therefore, close attention should be paid to children with pneumonia less than 5 years old during the COVID-19 pandemic.", "cite_spans": [{"start": 233, "end": 252, "text": "(Dong et al., 2020)", "ref_id": "BIBREF2"}, {"start": 434, "end": 456, "text": "(Wardlaw et al., 2006)", "ref_id": "BIBREF12"}, {"start": 544, "end": 566, "text": "(Wardlaw et al., 2006)", "ref_id": "BIBREF12"}], "ref_spans": [], "section": "INTRODUCTION"}, {"text": "Influenza viruses have precipitated pandemics several times over the past 100 years, specifically in 1918, 1957, 1968 and 2009 . Influenza A was a common cause of pneumonia in young children (Jain et al., 2015) . Recently, Kong et al retrospectively investigated the presence of SARS-CoV-2 among local patients with influenza like illness (ILI) from 6", "cite_spans": [{"start": 74, "end": 126, "text": "100 years, specifically in 1918, 1957, 1968 and 2009", "ref_id": null}, {"start": 191, "end": 210, "text": "(Jain et al., 2015)", "ref_id": "BIBREF6"}], "ref_spans": [], "section": "INTRODUCTION"}, {"text": "October 2019 to 21 January 2020 and found SARS-CoV-2 RNA was detected in nine ILI patient specimens (Kong et al., 2020) . In addition, ILI data for the 2019-2020 winter was significantly higher in comparison to previous years about children, suggested it was necessary to distinguish the difference between influenza A and COVID-19 young children with pneumonia. Therefore, the aim of this study was to compare the different clinical Page 5 of 15 J o u r n a l P r e -p r o o f 5 presentations between patients with infected with COVID-19 pneumonia versus influenza A pneumonia, to provide some recommendations for their differential diagnosis.", "cite_spans": [{"start": 100, "end": 119, "text": "(Kong et al., 2020)", "ref_id": "BIBREF7"}], "ref_spans": [], "section": "INTRODUCTION"}, {"text": "Subjects of the study were consecutive children with either confirmed COVID-19 pneumonia (admitted between 28 January and 11 March 2020) or influenza A pneumonia (admitted between 14 December 2019 and 30 February 2020) in Wuhan Children's hospital.", "cite_spans": [], "ref_spans": [], "section": "Study design and participants"}, {"text": "The study was approved by the Research Ethics Board of WuHan Children's Hospital (No. 2020003) . Consent of the patients' legal guardians was obtained.", "cite_spans": [{"start": 81, "end": 94, "text": "(No. 2020003)", "ref_id": null}], "ref_spans": [], "section": "Study design and participants"}, {"text": "Children were included in the study if they had evidence consistent with pneumonia as assessed by means of chest radiography or CT within 72 hours before or after admission. The virus nucleic acid detection kit was confirmed COVID-19 patients through detecting the RNA of SARS-CoV-2 in throat swab samples using based on the manufacturer's protocol (Shanghai BioGerm Medical Biotechnology Co.,Ltd). Influenza A was detected by direct immunofluorescence assay. The diagnostic criteria for severe pneumonia caused by SARS-CoV-2 and influenza A conform to guideline (2020, Harper et al., 2009 ).", "cite_spans": [{"start": 570, "end": 589, "text": "Harper et al., 2009", "ref_id": "BIBREF4"}], "ref_spans": [], "section": "Definitions"}, {"text": "A COVID-19 or influenza A case report form was designed to document primary data regarding demographic, clinical and laboratory characteristics from electronic medical records. The following information was extracted from each patient: gender, age, medical history, chief complaints, laboratory findings and computed tomography (CT) imaging on admission.", "cite_spans": [], "ref_spans": [], "section": "Data collection"}, {"text": "Categorical data were described as percentages, and continuous data as median with standard deviation (SD). Nonparametric comparative test for continuous data and \u03c7 2 test for categorical data were used to compare variables between groups. The statistical analyses were performed using SPSS Statistics version 25.0 software. P<0.05 was considered statistically significant.", "cite_spans": [], "ref_spans": [], "section": "Statistical analysis"}, {"text": "A total of 57 COVID-19 patients and 59 influenza A patients were included (Table 1) . No significant differences were found in the median age between COVID-19 patients and influenza A patients (18.7 months vs. 21.8 months, P = 0.121). The proportion of male was also not significantly different between the two groups (61.4% vs. 66.1%, P = 0.599). The most common symptoms and signs were cough (84.5%), fever (69.8%) and gastrointestinal symptoms (25%), whereas dyspnea (6.0%) and convulsions (3.4%) were less common. ", "cite_spans": [], "ref_spans": [{"start": 74, "end": 83, "text": "(Table 1)", "ref_id": "TABREF1"}], "section": "Baseline characteristics of COVID-19 and influenza A patients"}, {"text": "For blood inflammatory indictors, lower levels of C-reactive protein (CRP), procalcitonin (PCT) were observed in COVID-19 patients than influenza A patients ( Table 2 ).", "cite_spans": [], "ref_spans": [{"start": 159, "end": 166, "text": "Table 2", "ref_id": "TABREF2"}], "section": "Laboratory and imaging findings between COVID-19 and influenza A patients"}, {"text": "In terms of CT imaging, ground-glass opacification in chest CT was more common in COVID-19 patients than in influenza A patients (42.1% vs. 15%, P = 0.032). In contrast, consolidation was more common in influenza A patients (25%) than that in COVID-19 patients (5.2%, P = 0.025) ( Fig. 1 and Table 3 ). As we found before, cough and fever were the common symptoms in COVID-19 (Lu et al., 2020) , which is similar with influenza A. Our present study revealed that COVID-19 manifested as mild, severe pneumonia were less than influenza A patients. Some COVID-19", "cite_spans": [{"start": 376, "end": 393, "text": "(Lu et al., 2020)", "ref_id": "BIBREF8"}], "ref_spans": [{"start": 281, "end": 287, "text": "Fig. 1", "ref_id": "FIGREF2"}, {"start": 292, "end": 299, "text": "Table 3", "ref_id": "TABREF4"}], "section": "Laboratory and imaging findings between COVID-19 and influenza A patients"}, {"text": "patients only presented as fever or cough. Meanwhile, influenza A patients were more likely to be fever with higher temperature. Gastrointestinal symptoms were supposed to be common in patients with COVID-19 (Cheung et al., 2020) , however, were less when compared with influenza A. Convulsions could be found in both patients, but the reason was different, as only one in COVID-19 was secondary to pneumonia and three in influenza A were confirmed as febrile convulsion.", "cite_spans": [{"start": 208, "end": 229, "text": "(Cheung et al., 2020)", "ref_id": null}], "ref_spans": [], "section": "Since"}, {"text": "Lymphopenia and raise in D-dimer were the common laboratory abnormality in COVID-19 adult (Huang et al., 2020 and were proved as the caution of severity in COVID-19 (Ruan et al., 2020 , Zheng et al., 2020 . In our study, lymphocyte count and D-dimer were lower in influenza A patients than in COVID-19, which could further prove that COVID-19 is milder than influenza A. Similarly, CRP (C-reactive protein) and PCT (procalcitonin), which was the severity index of pneumonia, were lower in COVID-19 than influenza A.", "cite_spans": [{"start": 90, "end": 109, "text": "(Huang et al., 2020", "ref_id": "BIBREF5"}, {"start": 165, "end": 183, "text": "(Ruan et al., 2020", "ref_id": "BIBREF9"}, {"start": 184, "end": 204, "text": ", Zheng et al., 2020", "ref_id": null}], "ref_spans": [], "section": "Since"}, {"text": "In our study, we found that ground-glass opacity was more common in COVID-19 patients than in influenza A patients, whereas consolidation was more frequent in influenza A patients, which was consistent with previous studies. The radiological findings of children with COVID-19 pneumonia from our team and other study showed that ground-glass opacities were the most common pattern of abnormalities in chest CT (Chang et al., 2020) .", "cite_spans": [{"start": 410, "end": 430, "text": "(Chang et al., 2020)", "ref_id": null}], "ref_spans": [], "section": "Since"}, {"text": "Additionally, studies on influenza A-associated pneumonia showed that consolidation was common on CT (Guo et al., 2012) . Therefore, these differential pathological changes may contribute to distinguish imaging characteristics during clinical assessments.", "cite_spans": [{"start": 101, "end": 119, "text": "(Guo et al., 2012)", "ref_id": "BIBREF3"}], "ref_spans": [], "section": "Since"}, {"text": "There were some limitations of our present study. First, this was a retrospective study that included data from a single-center cohort. We hope for prospective cohort and multi-center study. Second, influenza A was diagnosis by direct immunofluorescence assay and failed to be typed.", "cite_spans": [], "ref_spans": [], "section": "Since"}, {"text": "In conclusion, COVID-19 patients were mild not only in clinical symptoms but also in laboratory examinations which including lymphocyte, CRP, PCT, D-dimer in the children under 5 years. Additionally, imaging results more commonly presented as ground-glass opacity in COVID-19 patients.", "cite_spans": [], "ref_spans": [], "section": "Since"}, {"text": "The authors declare that they have no conflict of interest.", "cite_spans": [], "ref_spans": [], "section": "Conflict of interest"}, {"text": "This study was approved by the Research Ethics Board of WuHan Children's Hospital (No.", "cite_spans": [], "ref_spans": [], "section": "Ethical approval"}, {"text": "WHCH 2020003).", "cite_spans": [], "ref_spans": [], "section": "Ethical approval"}, {"text": "[ ", "cite_spans": [], "ref_spans": [], "section": "REFERENCES:"}], "bib_entries": {"BIBREF0": {"ref_id": "b0", "title": "Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the", "authors": [{"first": "K", "middle": ["S"], "last": "Cheung", "suffix": ""}, {"first": "I", "middle": ["F"], "last": "Hung", "suffix": ""}, {"first": "P", "middle": ["P"], "last": "Chan", "suffix": ""}, {"first": "K", "middle": ["C"], "last": "Lung", "suffix": ""}, {"first": "E", "middle": [], "last": "Tso", "suffix": ""}, {"first": "R", "middle": [], "last": "Liu", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF1": {"ref_id": "b1", "title": "Hong Kong Cohort and Systematic Review and Meta-analysis", "authors": [], "year": 2020, "venue": "Gastroenterology", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1053/j.gastro.2020.03.065"]}}, "BIBREF2": {"ref_id": "b2", "title": "Epidemiology of COVID-19 Among Children in China", "authors": [{"first": "Y", "middle": [], "last": "Dong", "suffix": ""}, {"first": "X", "middle": [], "last": "Mo", "suffix": ""}, {"first": "Y", "middle": [], "last": "Hu", "suffix": ""}, {"first": "X", "middle": [], "last": "Qi", "suffix": ""}, {"first": "F", "middle": [], "last": "Jiang", "suffix": ""}, {"first": "Z", "middle": [], "last": "Jiang", "suffix": ""}], "year": 2020, "venue": "Pediatrics", "volume": "", "issn": "6", "pages": "", "other_ids": {}}, "BIBREF3": {"ref_id": "b3", "title": "Radiological findings in 210 paediatric patients with viral pneumonia: a retrospective case study", "authors": [{"first": "W", "middle": [], "last": "Guo", "suffix": ""}, {"first": "J", "middle": [], "last": "Wang", "suffix": ""}, {"first": "M", "middle": [], "last": "Sheng", "suffix": ""}, {"first": "M", "middle": [], "last": "Zhou", "suffix": ""}, {"first": "L", "middle": [], "last": "Fang", "suffix": ""}], "year": null, "venue": "The British journal of radiology", "volume": "85", "issn": "", "pages": "1385--1394", "other_ids": {}}, "BIBREF4": {"ref_id": "b4", "title": "Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of", "authors": [{"first": "S", "middle": ["A"], "last": "Harper", "suffix": ""}, {"first": "J", "middle": ["S"], "last": "Bradley", "suffix": ""}, {"first": "J", "middle": ["A"], "last": "Englund", "suffix": ""}, {"first": "T", "middle": ["M"], "last": "File", "suffix": ""}, {"first": "S", "middle": [], "last": "Gravenstein", "suffix": ""}, {"first": "F", "middle": ["G"], "last": "Hayden", "suffix": ""}], "year": 2009, "venue": "America", "volume": "48", "issn": "8", "pages": "1003--1035", "other_ids": {}}, "BIBREF5": {"ref_id": "b5", "title": "Clinical features of patients infected with 2019 novel coronavirus in Wuhan", "authors": [{"first": "C", "middle": [], "last": "Huang", "suffix": ""}, {"first": "Y", "middle": [], "last": "Wang", "suffix": ""}, {"first": "X", "middle": [], "last": "Li", "suffix": ""}, {"first": "L", "middle": [], "last": "Ren", "suffix": ""}, {"first": "J", "middle": [], "last": "Zhao", "suffix": ""}, {"first": "Y", "middle": [], "last": "Hu", "suffix": ""}], "year": 2020, "venue": "China. Lancet", "volume": "395", "issn": "", "pages": "497--506", "other_ids": {}}, "BIBREF6": {"ref_id": "b6", "title": "Community-Acquired Pneumonia Requiring Hospitalization among U", "authors": [{"first": "S", "middle": [], "last": "Jain", "suffix": ""}, {"first": "W", "middle": ["H"], "last": "Self", "suffix": ""}, {"first": "R", "middle": ["G"], "last": "Wunderink", "suffix": ""}, {"first": "S", "middle": [], "last": "Fakhran", "suffix": ""}, {"first": "R", "middle": [], "last": "Balk", "suffix": ""}, {"first": "A", "middle": ["M"], "last": "Bramley", "suffix": ""}], "year": 2015, "venue": "S. Adults. The New England journal of medicine", "volume": "373", "issn": "5", "pages": "415--442", "other_ids": {}}, "BIBREF7": {"ref_id": "b7", "title": "SARS-CoV-2 detection in patients with influenza-like illness", "authors": [{"first": "W", "middle": ["H"], "last": "Kong", "suffix": ""}, {"first": "Y", "middle": [], "last": "Li", "suffix": ""}, {"first": "M", "middle": ["W"], "last": "Peng", "suffix": ""}, {"first": "D", "middle": ["G"], "last": "Kong", "suffix": ""}, {"first": "X", "middle": ["B"], "last": "Yang", "suffix": ""}, {"first": "L", "middle": [], "last": "Wang", "suffix": ""}], "year": 2020, "venue": "Nature microbiology", "volume": "5", "issn": "5", "pages": "675--683", "other_ids": {}}, "BIBREF8": {"ref_id": "b8", "title": "SARS-CoV-2 Infection in Children", "authors": [{"first": "X", "middle": [], "last": "Lu", "suffix": ""}, {"first": "L", "middle": [], "last": "Zhang", "suffix": ""}, {"first": "H", "middle": [], "last": "Du", "suffix": ""}, {"first": "J", "middle": [], "last": "Zhang", "suffix": ""}, {"first": "Y", "middle": ["Y"], "last": "Li", "suffix": ""}, {"first": "J", "middle": [], "last": "Qu", "suffix": ""}], "year": 2020, "venue": "The New England journal of medicine", "volume": "382", "issn": "17", "pages": "1663--1668", "other_ids": {}}, "BIBREF9": {"ref_id": "b9", "title": "Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan", "authors": [{"first": "Q", "middle": [], "last": "Ruan", "suffix": ""}, {"first": "K", "middle": [], "last": "Yang", "suffix": ""}, {"first": "W", "middle": [], "last": "Wang", "suffix": ""}, {"first": "L", "middle": [], "last": "Jiang", "suffix": ""}, {"first": "J", "middle": [], "last": "Song", "suffix": ""}], "year": 2020, "venue": "China. Intensive care medicine", "volume": "46", "issn": "5", "pages": "846--854", "other_ids": {}}, "BIBREF11": {"ref_id": "b11", "title": "Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China", "authors": [], "year": 2020, "venue": "Jama", "volume": "323", "issn": "11", "pages": "1061--1070", "other_ids": {}}, "BIBREF12": {"ref_id": "b12", "title": "Pneumonia: the leading killer of children", "authors": [{"first": "T", "middle": [], "last": "Wardlaw", "suffix": ""}, {"first": "P", "middle": [], "last": "Salama", "suffix": ""}, {"first": "E", "middle": ["W"], "last": "Johansson", "suffix": ""}, {"first": "E", "middle": [], "last": "Mason", "suffix": ""}], "year": 2006, "venue": "Lancet", "volume": "368", "issn": "9541", "pages": "1048--50", "other_ids": {}}, "BIBREF17": {"ref_id": "b17", "title": "MB isoenzyme of creatine kinase; BUN, blood urea nitrogen", "authors": [{"first": "Creatinine", "middle": [], "last": "Ck", "suffix": ""}, {"first": ";", "middle": [], "last": "Ck-Mb", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}}, "ref_entries": {"FIGREF0": {"text": "3.7 vs. 15.1 mg/L, P = 0.001; 0.09 vs. 0.68 ng/ml, P < 0.001). For blood routine test, COVID-19 patients showed significantly lower levels of leukocytes and neutrophils, while lymphocyte levels were significantly higher compared with influenza A patients (7.87 vs. 9.89 \u00d710 9 /L, P = 0.027; 2.43 vs. 5.16 \u00d710 9 /L, P < 0.001; 4.58 vs. 3.56 \u00d710 9 /L; P = 0.006). For biochemistry testing, no significant differences were found in the alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin (ALB); Bilirubin, blood urea nitrogen (BUN) and blood creatinine between the two groups of patients. However, lower levels of D-dimer and prothrombin time (PT) and Potassium ion were found in COVID-19 patients than influenza A patients (0.34 vs. 1.94, P < 0.001; 10.8 vs. 11.2 mm/h, P = 0.014; 5.14 vs. 7.07 mmol/L, P = 0.001) (", "latex": null, "type": "figure"}, "FIGREF1": {"text": "December 2019, an outbreak of coronavirus disease 2019 (COVID-19) has spread globally. The outbreak of COVID-19 began in December 2019, which also corresponded with the flu season in China(Yu et al., 2013). It is important to differentiate these two respiratory infectious diseases via early clinical presentation in consideration of their different therapies, prognoses, and protective measures. In this study, we first compared the courses of pneumonia caused by SARS-CoV-2 and influenza A virus. We found that COVID-19 patients were mild in clinical symptoms and laboratory examinations in the children under 5 years. Additionally, imaging results more commonly presented as ground-glass opacity in COVID-19 patients.", "latex": null, "type": "figure"}, "FIGREF2": {"text": "Recommendations for the diagnosis, prevention and control of the 2019 novel coronavirus infection in children (first interim edition)]. Zhonghua er ke za zhi = Chinese journal of pediatrics 2020;58(3):169-74. Chang TH, Wu JL, Chang LY. Clinical characteristics and diagnostic challenges of pediatric COVID-19: A systematic review and meta-analysis. Journal of the Formosan Medical Association = Taiwan yi zhi 2020;119(5):982-9. patterns in China and implications for vaccination strategies: spatio-temporal modeling of surveillance data. PLoS medicine 2013;10(11):e1001552. Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. The Journal of infection 2020;10.1016/j.jinf.2020.04.021. Imaging characteristics of chest CT from COVID-19 and influenza A patients. (a) A 1-year-old boy with COVID-19 exhibited ground-glass opacity mixed consolidation in both lungs. (b) A 7-month-old girl with COVID-19 exhibited ground-glass opacities in left lung. (c) A 1-month-old boy with COVID-19 exhibited consolidation in right lung. (d) A 1year-old boy with influenza A exhibited exudation and consolidation distributed diffusely in both lungs. (e) A 2-year-old girl with influenza A exhibited consolidation in right lung. (f) A 2-year-old boy with influenza A exhibited consolidation in left lung and ground-glass opacity in right lung.", "latex": null, "type": "figure"}, "TABREF0": {"text": "Moreover, the proportions of cough (70.2%), fever (54.4%) and gastrointestinal symptoms (14.1%) in COVID-19 patients were lower than those of influenza A patients (98.3%, P < 0.001; 84.7%, P < 0.001; and 35.6%, P = 0.007; respectively). Additionally, the highest body temperature of influenza A patients was also significantly higher than that of COVID-19 patients (38.5 \u00b0C vs. 39.3 \u00b0C, P < 0.001). The proportion of severe pneumonia in patients was also lower than that in patients infected with influenza A (3.5% vs. 18.6%, P = 0.016) (Table 1).", "latex": null, "type": "table"}, "TABREF1": {"text": "Characteristics of patients with COVID-19 or influenza A.", "latex": null, "type": "table", "html": "<html><body><table><tr><td>Variable </td><td>Total (n=116) </td><td>No. (%) or median \u00b1 SD COVID-19 (n=57) </td><td>Influenza A (n=59) </td><td>p value </td></tr><tr><td>Male </td><td>74 (63.8) </td><td> 35 (61.4) </td><td>39 (66.1) </td><td>0.599 </td></tr><tr><td>Age (months) </td><td>20.2 \u00b1 16.7 </td><td>18.7 \u00b1 16.7 </td><td>21.8 \u00b1 16.7 </td><td>0.121 </td></tr><tr><td>Severe pneumonia </td><td>13 (11.2) </td><td> 2 (3.5) </td><td>11 (18.6) </td><td>0.016 </td></tr><tr><td>Symptoms and signs </td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td> Fever </td><td>81 (69.8) </td><td>31 (54.4) </td><td>50 (84.7) </td><td>p&lt;0.001 </td></tr><tr><td> Highest temperature (\u00b0C) </td><td>38.9 \u00b1 0.7 98 (84.5) 7 (6.0) 29 (25) 4 (3.4) 8 (6.9) 6 (5.2) </td><td>re38.5 \u00b1 0.7 40 (70.2) 2 (3.5) 8 (14.1) 1 (1.7) 1 (1.7) 2 (3.5) </td><td> P-proof\n39.3 \u00b1 0.6 58 (98.3) 5 (8.5) 21 (35.6) 3 (5.1) 7 (11.8) 4 (6.7) number; SD, standard deviation; IC</td><td>p&lt;0.001 </td></tr><tr><td> Cough </td><td>\u00a0</td><td>\u00a0</td><td>p&lt;0.001 </td></tr><tr><td> Dyspnea </td><td>\u00a0</td><td>\u00a0</td><td>0.439 </td></tr><tr><td> Gastrointestinal symptoms </td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>0.007 </td></tr><tr><td> Convulsions </td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>0.619 </td></tr><tr><td>Hospitalized treatment Oxygen inhalation </td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>0.061 </td></tr><tr><td> ICU </td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>0.679 </td></tr><tr><td>Care Unit. </td><td>COVID-19, coronavirus disease 2019; No., U, Intensive </td></tr></table></body></html>"}, "TABREF2": {"text": "Laboratory findings of COVID-19 and influenza A patients.", "latex": null, "type": "table", "html": "<html><body><table><tr><td>Variable </td><td>Total (n=116) </td><td>No. (%) or median \u00b1 SD COVID-19 (n=57) </td><td>Influenza A (n=59) </td><td>p value </td></tr><tr><td>Blood routine test </td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td> Leukocytes (\u00d7109/L) </td><td>8.88 \u00b1 4.07 </td><td>7.87 \u00b1 2.87 </td><td>9.89 \u00b1 4.84 </td><td>0.027 </td></tr><tr><td> Neutrophils (\u00d7109/L) </td><td>3.81 \u00b1 3.69 </td><td>2.43 \u00b1 1.92 </td><td>5.16 \u00b1 4.46 </td><td>p &lt; 0.001 </td></tr><tr><td> Lymphocytes (\u00d7109/L) </td><td>4.06 \u00b1 2.09 </td><td>4.58 \u00b1 2.06 </td><td>3.56 \u00b1 2.01 </td><td>0.006 </td></tr><tr><td> Platelets (\u00d7109/L) </td><td>304 \u00b1 110 </td><td>298 \u00b1 107 </td><td>311 \u00b1 113 </td><td>0.455 </td></tr><tr><td> Hemoglobin((g/L)) </td><td>rnal 117 \u00b1 11 10.9 \u00b1 0.8 33.6 \u00b1 5.4 0.8 \u00b1 1.7 9.5 \u00b1 24.1 0.41 \u00b1 1.35 31 \u00b1 57 54 \u00b1 64 7.44 \u00b1 4.53 43.1 \u00b1 5.5 138 \u00b1 106 338 \u00b1 128 42 \u00b1 32 28.6 \u00b1 29.9 3.3 \u00b1 1.7 </td><td>Pre-proof\n117 \u00b1 11 1110.8 \u00b1 0.7 11.33.4 \u00b1 5.2 34.0.34 \u00b1 0.29 1.94 3.7 \u00b1 6.85 15.1 0.09 \u00b1 0.09 0.68 36 \u00b1 78 26 57 \u00b1 86 50 7.35 \u00b1 4.58 42.7 \u00b1 6.9 147 \u00b1 89 319 \u00b1 92 38 \u00b1 20 26.5 \u00b1 24.7 3.48 \u00b1 2.24 </td><td>7 \u00b1 12 2 \u00b1 0.8 1 \u00b1 5.9 \u00b1 2.88 \u00b1 32.2 \u00b1 1.82 \u00b1 25 \u00b1 30 7.51 \u00b1 4.52 43.5 \u00b1 3.6 130 \u00b1 121 357 \u00b1 154 46 \u00b1 41 30.6 \u00b1 34.2 3.24 \u00b1 1.15 </td><td>0.932 </td></tr><tr><td>Coagulation function PT (s) </td><td>\u00a0</td><td>\u00a0</td><td>0.014 </td></tr><tr><td> APTT (s) </td><td>\u00a0</td><td>\u00a0</td><td>0.650 </td></tr><tr><td> D-Dimer (ng/ml) </td><td>\u00a0</td><td>\u00a0</td><td>p &lt; 0.001 </td></tr><tr><td>Inflammatory indictors </td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td> CRP (mg/dl) </td><td>\u00a0</td><td>\u00a0</td><td>0.001 </td></tr><tr><td> PCT (ng/ml) </td><td>\u00a0</td><td>\u00a0</td><td>p &lt; 0.001 </td></tr><tr><td>Biochemical test ALT (U/L) </td><td>\u00a0</td><td>\u00a0</td><td>0.595 </td></tr><tr><td> AST (U/L) </td><td>Jouonavirus disease 2019; No.</td><td>\u00a0</td><td>0.591 </td></tr><tr><td> TIBL (umol/L) </td><td>\u00a0</td><td>0.799 </td></tr><tr><td> ALB (g/L) </td><td>\u00a0</td><td>0.964 </td></tr><tr><td> CK (U/L) </td><td>\u00a0</td><td>0.042 </td></tr><tr><td> LDH (U/L) </td><td>\u00a0</td><td>0.340 </td></tr><tr><td> CK-MB (U/L) </td><td>\u00a0</td><td>1.000 </td></tr><tr><td> Creatinine (umol/L) </td><td>\u00a0</td><td>0.939 </td></tr><tr><td> BUN (mmol/L) </td><td>COVID-19, cor, number; SD, standard deviation; CRP, C-reactive </td><td>0.122 </td></tr></table></body></html>"}, "TABREF3": {"text": "CT Imaging findings of patients with COVID-19 or influenza A at presentation. Characteristics of patients with COVID-19 or Influenza A.COVID-19, coronavirus disease 2019; No., number; SD, standard deviation; ICU, Intensive Care Unit.", "latex": null, "type": "table"}, "TABREF4": {"text": "CT Imaging findings of patients with COVID-19 or H1N1 at presentation. COVID-19, coro1navirus disease 2019; CT, computed tomography; No., number.", "latex": null, "type": "table"}, "TABREF5": {"text": "Table 3. CT Imaging findings of patients with COVID-19 or H1N1 at presentation.", "latex": null, "type": "table", "html": "<html><body><table><tr><td>Variable </td><td>\u00a0</td><td>No. (%) </td><td>\u00a0</td><td>p value </td></tr><tr><td>Total (n=77) </td><td>COVID-19 (n=57) </td><td>H1N1 (n=20) </td><td>\u00a0</td></tr><tr><td>Patterns of the lesion </td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td> Ground glass opacification </td><td>24 (20.7) </td><td>24 (42.1) </td><td>3 (15) </td><td>0.032 </td></tr><tr><td> Consolidation </td><td>8 (6.9) </td><td>3 (5.2) </td><td>5 (25) </td><td>0.025 </td></tr></table></body></html>"}}, "back_matter": []}